Prediction of Treatment Failures in Induction of Remission With Oral Mesalamine in Mild-to-Moderately Active Ulcerative Colitis

被引：0
|
作者：
Kruis, Wolfgang
Mueller, Ralph
Greinwald, Roland
机构：
来源：
GASTROENTEROLOGY | 2012年 / 142卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S205 / S205
页数：1
相关论文
共 50 条
  • [1] MMX mesalazine for the induction of remission of mild-to-moderately active ulcerative colitis: efficacy and tolerability in specific patient subpopulations
    Lichtenstein, G. R.
    Kamm, M. A.
    Sandborn, W. J.
    Lyne, A.
    Joseph, R. E.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (11) : 1094 - 1102
  • [2] High- and Low-Dose Oral Delayed-Release Mesalamine in Children With Mild-to-Moderately Active Ulcerative Colitis
    Winter, Harland S.
    Krzeski, Piotr
    Heyman, Melvin B.
    Ibarguen-Secchia, Eduardo
    Iwanczak, Barbara
    Kaczmarski, Maciej
    Kierkus, Jaroslaw
    Kolacek, Sanja
    Osuntokun, Bankole
    Quiros, J. Antonio
    Shah, Manoj
    Yacyshyn, Bruce
    Dunnmon, Preston M.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2014, 59 (06): : 767 - 772
  • [3] The Probiotic Preparation, VSL#3 Induces Remission in Patients With Mild-to-Moderately Active Ulcerative Colitis
    Sood, Ajit
    Midha, Vandana
    Makharia, Govind K.
    Ahuja, Vineet
    Singal, Dinesh
    Goswami, Pooja
    Tandon, Rakesh K.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2009, 7 (11) : 1202 - 1209
  • [4] Best practice in the management of mild-to-moderately active ulcerative colitis and achieving maintenance of remission using mesalazine
    Munkholm, Pia
    Michetti, Pierre
    Probert, Chris S.
    Elkjaer, Margarita
    Marteau, Philippe
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 22 (08) : 912 - 916
  • [5] Combined oral and rectal mesalazine for the treatment of mild-to-moderately active ulcerative colitis: Rapid symptom resolution and improvements in quality of life
    Probert, Christopher S. J.
    Dignass, Axel U.
    Lindgren, Stefan
    Pool, Marco Oudkerk
    Marteau, Philippe
    JOURNAL OF CROHNS & COLITIS, 2014, 8 (03): : 200 - 207
  • [6] Impact of Synbiotic Therapy on the Quality of Life in Patients with Mild-to-Moderately Active Ulcerative Colitis
    Altun, Hulya Kamarli
    Yildiz, Emine Akal
    Akin, Mete
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2022, 31 (04) : 417 - 423
  • [7] Quality of Life Improvements Attributed to Combination Therapy with Oral and Topical Mesalazine in Mild-to-Moderately Active Ulcerative Colitis
    Connolly, M. P.
    Poole, C. D.
    Currie, C. J.
    Marteau, P.
    Nielsen, S. K.
    DIGESTION, 2009, 80 (04) : 241 - 246
  • [8] Effect of once- or twice-daily MMX mesalamine (SPD476) for the induction of remission of mild to moderately active ulcerative colitis
    Lichtenstein, Gary R.
    Kamm, Michael A.
    Boddu, Prabhakar
    Gubergrits, Natalya
    Lyne, Andrew
    Butler, Todd
    Lees, Kirstin
    Joseph, Raymond E.
    Sandborn, William J.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2007, 5 (01) : 95 - 102
  • [9] Adalimumab for Induction of Histological Remission in Moderately to Severely Active Ulcerative Colitis
    Ignacio Fernandez-Blanco, J.
    Fernandez-Diaz, Guillermo
    Cara, Carlos
    Vera, Maria I.
    Olivares, David
    Taxonera, Carlos
    DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (03) : 731 - 737
  • [10] Mesalamine in the treatment and maintenance of remission of ulcerative colitis
    Ham, Maggie
    Moss, Alan C.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2012, 5 (02) : 113 - 123
12345